ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

TYRA vs INVA // OPTIONS IMPLIED MOVE & PUT/CALL SKEW

Tyra Biosciences Inc. (NASDAQ) VS. Innoviva Inc. (NASDAQ) • 15-METRIC TALLY: TYRA 0 — INVA 5
■ METRIC PARITY
options-implied-move
—
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TYRA VS. INVA) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC TYRA INVA SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 74.80% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% 14.70% -49.70 INVA /roic <GO>
EV/EBITDA & P/E Valuation — 7.6x — TIE /valuation <GO>
Free Cash Flow Yield -6.45% 12.72% -19.17 INVA /fcf-yield <GO>
Operating Margin — 39.80% — TIE /operating-margins <GO>
Net Profit Margin — — — TIE /net-margins <GO>
Revenue Growth (YoY) — 14.70% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 6/9 -4.00 INVA /piotroski-score <GO>
Options Implied Move & Put/Call Skew ACTIVE — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 51.8 54.7 -2.90 INVA /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $1.48B $1.54B -$62.7M INVA /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR TYRA REV INVA REV TYRA GROSS % INVA GROSS % TYRA FCF INVA FCF
FY 2025 $0 $411.3M — 74.8% -$95.3M $195.8M
FY 2024 $0 $358.7M — 82.6% -$70.4M $188.4M
FY 2023 $0 $310.5M — — -$50.1M $141.1M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TYRA // BETA —
INVA // BETA —